Pharming Group Balance Sheet Health
Financial Health criteria checks 5/6
Pharming Group has a total shareholder equity of $225.8M and total debt of $95.4M, which brings its debt-to-equity ratio to 42.3%. Its total assets and total liabilities are $425.5M and $199.7M respectively.
Key information
42.3%
Debt to equity ratio
US$95.42m
Debt
| Interest coverage ratio | n/a |
| Cash | US$171.77m |
| Equity | US$225.79m |
| Total liabilities | US$199.72m |
| Total assets | US$425.51m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: PHGN's short term assets ($282.2M) exceed its short term liabilities ($79.8M).
Long Term Liabilities: PHGN's short term assets ($282.2M) exceed its long term liabilities ($119.9M).
Debt to Equity History and Analysis
Debt Level: PHGN has more cash than its total debt.
Reducing Debt: PHGN's debt to equity ratio has reduced from 59.8% to 42.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PHGN has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if PHGN has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.